With this second add-on, the Favillini Group becomes Italy's leading player in secondary packaging for the pharmaceutical and nutraceutical industry.
LIVORNO, Italy - Feb. 3, 2025 - PRLog -- Favillini, historic Leghorn-based paper manufacturer founded in 1886, focused on the production of secondary packaging for the pharmaceutical and nutraceutical industry (cartons and leaflets), has completed the acquisition of 100% of Interpack S.p.A. based in Pomezia (Rome), operating in the same market segment and controlled by Oxy Capital through Gpack S.p.A.
From 2020, following the entry of Arcadia SGR into the shareholding structure, Favillini undertook a process of growth both organically, with major investments in technology and production capacity, and by external lines, consolidating the fragmented Italian pharmaceutical and nutraceutical secondary packaging market. With its first add-on, Ideagrafica, a company based in Liscate, in the Milan area, the group expanded its geographic coverage in northern Italy, entering the nutraceutical sector and broadening its commercial offer with the addition of information pamphlets to the folding carton boxes.
With the acquisition of the Lazio company Interpack, Favillini now completes its strategic coverage of the Italian market with the presidium of the third Italian pharmaceutical district, after Lombardy and Tuscany, becoming the leading operator in Italy in the production of secondary packaging for the pharmaceutical and nutraceutical sectors. With approximately 850 million pieces produced, the group will reach a consolidated turnover of over 45 million Euro in 2025, developed in three production plants with a total surface area of over 20,000 square metres and over 200 employees.
Eugenio Favillini, CEO of the group, commented, 'We are very pleased with the entry of Interpack into the Favillini Group, sure that this will give the ambitious development project already started together with Ideagrafica a further boost to growth. In this way we believe we have created a market leader that can increasingly act as a reliable reference for customers in the pharmaceutical and nutraceutical sectors in Italy'.
Enrico Luciano, Chairman of the Gpack Group that sold Interpack, commented "Following the turnaround of Interpack, carried out by Pierpaolo Bramucci as part of the broader turnaround process of the Gpack Group, launched in 2021 by Oxy Capital with the support of Illimity Bank, we are very proud to entrust Interpack to the Favillini Group, certain that this is the best landing place for a pharmaceutical packaging company of Interpack's size, in order to further grow thanks to the expertise and relationships of market leader Favillini."
The advisors involved in the transaction were:
for the Favillini Group:
- Financial Advisor: CDI Global (Cesare Tocchio)
- Due diligence and legal assistance: Advant NCTM (Matteo Trapani, Giovanni de Capitani, Giulia Martina Fiorelli, Andrea Bertoni, Eleonora Bellavita)
- Financial due diligence: New Deal Advisors (Guido Pelissero e Gaetano Attanasio)
- ESG due diligence: ERM (Giovanni Aquaro e Andrea Perna)
- Tax due diligence: Studio Russo de Rosa (Leo De Rosa, Alessandro Manias, Andrea Massaccesi, Mimmo Lombardi, Gian Maria Garzi) for Interpack/Gpack:
- Legal assistance: Studio Bonelli Erede (Federico Vermicelli, Pierangelo Totaro e Francesca Dominici)
The financing for the acquisition was provided by Credit Agricole with the support of Simmons & Simmons (Francesco Burla). For Arcadia, the operation was supervised by Guido Belli, Stefano Piras and Valentina Fontanesi.
***
Arcadia SGR is an independent, management-controlled asset management company specialising in investments in the capital of small and medium-sized Italian companies. Currently raising a third fund called Arcadia Sustainable Capital III, in Art. 8 of the SFDR and PIR compliant, Arcadia recently liquidated its first fund, Arcadia Small Cap, realising double-digit returns for its investors. The professionals in Arcadia's team have gained deep and articulate experience with an approach to investment that implies proactive involvement and concrete support in the design and implementation of organic growth and acquisition plans, aimed at changing the size scale and strategic value of investees. Since 2020, Arcadia has been committed to promoting sustainability on the basis of an ESG policy and specific training actions coordinated by an in-house ESG Manager, and since 2021 has been a signatory of the PRI (Principles for Responsible Investment) principles.
Photos: (Click photo to enlarge)
Source: CDI Global
Read Full Story - CDI Global Advised Favillini Pharmaceutical Packaging Group S.p.A. (Favillini) in acquisition of Interpack S.p.A | More news from this source
Press release distribution by PRLog